Breast Cancer Research and Treatment

Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer
pp. 1-6(6)
Authors: Ozmen, V.; Karanlik, H.; Cabioglu, N.; Igci, A.; Kecer, M.; Asoglu, O.; Tuzlali, S.; Mudun, A.

Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies
pp. 7-12(6)
Authors: Martin, Michelle; Hilsenbeck, Susan; Mohsin, Syed; Hopp, Torsten; Clark, Gary; Osborne, C.; Allred, D.; O'Connell, Peter

Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy
pp. 13-16(4)
Authors: Grabinski, J.L.; Smith, L.S.; Chisholm, G.B.; Drengler, R.; Rodriguez, G.I.; Lang, A.S.; Kalter, S.P.; Garner, A.M.; Fichtel, L.M.; Hollsten, J.; Pollock, B.H.; Kuhn, J.G.

Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation
pp. 17-27(11)
Authors: Contessa, Joseph; Abell, Angela; Mikkelsen, Ross; Valerie, Kristoffer; Schmidt-Ullrich, Rupert

Breast cancer risk assessment in the Czech female population – an adjustment of the original Gail model
pp. 29-35(7)
Authors: Novotny, Jan; Pecen, Ladislav; Petruzelka, Lubos; Svobodnik, Adam; Dusek, Ladislav; Danes, Jan; Skovajsova, Miloslava

Activation of vascular endothelial growth factor (VEGF) by the ER-α variant, ERΔ3
pp. 37-43(7)
Authors: Koduri, Sailaja; Goldhar, Anita; Vonderhaar, Barbara

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer
pp. 45-53(9)
Authors: Venturini, M.; Bighin, C.; Monfardini, S.; Cappuzzo, F.; Olmeo, N.; Durando, A.; Puglisi, F.; Nicoletto, O.; Lambiase, A.; Mastro, L.

A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients
pp. 55-64(10)
Authors: Cutuli, Bruno; Cottu, Paul; Guastalla, Jean; Mechin, Hubert; Costa, Anne; Jourdan, Rosemary

Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer
pp. 65-72(8)
Authors: Przybylowska, Karolina; Kluczna, Anita; Zadrozny, Marek; Krawczyk, Tadeusz; Kulig, Andrzej; Rykala, Jan; Kolacinska, Agnieszka; Morawiec, Zbigniew; Drzewoski, Jozef; Blasiak, Janusz

Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer
pp. 73-80(8)
Authors: Brewster, A.M.; Jorgensen, T.J.; Ruczinski, I.; Huang, H.Y.; Hoffman, S.; Thuita, L.; Newschaffer, C.; Lunn, R.M.; Bell, D.; Helzlsouer, K.J.

Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype–phenotype correlations
pp. 81-87(7)
Authors: Gallardo, Marcela; Silva, Antonia; Rubio, Lorena; Alvarez, Carolina; Torrealba, Carolina; Salinas, Mauricio; Tapia, Teresa; Faundez, Paola; Palma, Lorena; Riccio, María; Paredes, Hernando; Rodriguez, Mario; Cruz, Adolfo; Rousseau, Christine; King, Mary; Camus, Mauricio; Alvarez, Manuel; Carvallo, Pilar

The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida
pp. 89-95(7)
Authors: Voti, Lydia; Richardson, Lisa; Reis, Isildinha; Fleming, Lora; MacKinnon, Jill; Coebergh, Jan

Can the apparent conflicting roles of PKC δ on cell proliferation and survival be reconciled?
pp. 97-98(2)
Authors: Maioli, Emanuela; Vittoria, Fortino